Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Date:8/4/2009

y from irreversible joint damage. According to the National Institutes of Health, autoimmune disorders affect between 14.7 and 23.5 million people in the United States.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by the company's research team. The company has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX2931 and the potential therapeutic and commercial potential of LX2931. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX2931 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulato
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... retrospective study led by researchers at Brigham and ... colonoscopies for colorectal cancer screening and surveillance. The ... intervals than established guidelines support, and these recommendations ... , "Our study shows that a high percentage ... resulting in use of scarce health care resources ...
(Date:9/29/2014)... Atlantic NeuroSurgical Specialists (ANS) brain ... to celebrate their strides in their fight against brain cancer. ... at their Morristown office. , The annual BBQ has grown ... a place where patients can find love, hope and support ... and activities were enjoyed by guests, including a dunk tank ...
(Date:9/29/2014)... September 30, 2014 NAPW ... as a 2014 Professional Woman of the Year. Ms. ... in home healthcare. As the largest networking organization of ... and profession, the National Association of Professional Women is ... and nearly 300 Local Chapters. , “I love the ...
(Date:9/29/2014)... NY (PRWEB) September 30, 2014 ... B.S.N., Clinical Manager Specialist, as a 2014 Professional Woman ... prestigious distinction for leadership in clinical care. As the ... spanning virtually every industry and profession, the National Association ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:9/29/2014)... September 30, 2014 Top10BestSEOHosting.com is ... reviews about hosting products. It is headed by ... experience. The site offers research-based information and factual ... suppliers in the current market. , Top10BestSEOHosting.com ... announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and Bluehost ...
Breaking Medicine News(10 mins):Health News:Endoscopists recommend frequent colonoscopies, leading to its overuse 2Health News:Local Brain Tumor Foundation, ANS Center of Hope, Celebrates its Brain Cancer Patients 2Health News:National Association of Professional Women Announces Carol A. Stormer, Home Health Occupational at LHC GroupTherapist, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Sarah Shiermeister, Clinical Manager Specialist at Gentiva Health Services, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2
... standard for grading, staging and "stad-ging" the chronic liver ... acquiring new knowledge on the liver pathology. Demand for ... in liver biopsy samples has been fuelled by the ... molecules on the lesions characterising the histological patterns of ...
... 31 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the ... leading China-based medical device,company that develops, manufactures ... that the Company has completed the previously,announced ... tumor therapy system,business (the "HIFU Business") to ...
... in Near Term Continue Trading Under the Ticker ... HAXS ) and BPO Management Services, Inc., ... focused on serving middle-market enterprises, today jointly announced ... the previously announced merger in which BPOMS will ...
... Dec. 30 Scantek Medical, Inc. (Pink ... it filed a voluntary petition in the United States ... of the United States Code. Scantek also announced ... BreastCare(TM)/BreastAlert(TM) Differential Temperature Sensor product ("BreastCare") to a medical ...
... CAMBRIDGE, Mass., Dec. 30 Biopure Corporation (Nasdaq: ... has advised the U.S. Naval Medical Research Center ("NMRC") by ... Biopure,s product Hemopure [hemoglobin glutamer - 250 (bovine)], under a ... As previously announced, the Navy had filed a protocol ...
... Dec. 30 Biopure Corporation (Nasdaq: BPUR ... The NASDAQ Stock Market stating that NASDAQ has again ... value requirements for continued listing, thereby extending the Company,s ... these rules is scheduled to resume on Monday, April ...
Cached Medicine News:Health News:A rigorous method for liver biopsy 2Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 2Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 3Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 4Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 5Health News:Healthaxis and BPO Management Services, Inc. Announce Closing of Merger 2Health News:Healthaxis and BPO Management Services, Inc. Announce Closing of Merger 3Health News:Scantek Medical Files for Chapter 11 Voluntary Bankruptcy and Receives Orders for the Sale of BreastCare(TM) 2Health News:U.S. Navy Requested Operations Trial on FDA Hold 2Health News:U.S. Navy Requested Operations Trial on FDA Hold 3Health News:Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance 2
(Date:9/29/2014)... DUBLIN , Sept. 29, 2014 Research ... "Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018" ... sector is projected to reach US$5.7 billion by 2016. The ... global market share while Europe claims ... fastest growing region with a CAGR of 11.4% driving a ...
(Date:9/29/2014)... 2014  Guerbet, a pioneer in the field ... a Drug Shortage Assistance Award from the U.S. ... preventing or alleviating a drug shortage. ... to the shortage of Ethiodol (ethiodized oil) injection, ... post-approval supplements to restart manufacturing with acceptable compliance ...
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
Breaking Medicine Technology:Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018 2Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018 3Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018 4Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018 5Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3
... Catalyst system introduces a new ... to microsurgical instrumentation. It has ... design with advanced microcomputer control ... to operate with a full ...
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
... Horizon Phacoemulsification System is ... surgical system. Lightweight and ... performance and features in ... also provides all modes ...
Compact ultrasonic phacoemulsification system....
Medicine Products: